Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
03/17/1993 | CN1020103C 2,3,4,5,6,7-hexahydro-2,7-methylene-1,5-benzoxazonin and 1,4-benzoxazonin |
03/17/1993 | CN1020102C Preparation for bicyclic carboxylic ether and bicyclic carboxylic amide |
03/17/1993 | CN1020101C Process for preparation of tricycle kentones |
03/17/1993 | CN1020100C Process for benzopyran derivatives |
03/17/1993 | CN1020098C Production for thiolactam-N-acetic acid derivatives |
03/17/1993 | CN1020097C Process for substituted benzene derivative |
03/17/1993 | CN1020096C Preparation for imidazoline derivatives |
03/17/1993 | CN1020095C Process for dichloroaniline derivatives |
03/17/1993 | CN1020093C 1-phenyl -3-naphthalenyloxypropanamines |
03/17/1993 | CA2078265A1 Amide-substituted derivatives of spiroindanylcamphorsulfonyl oxytocin antagonists |
03/17/1993 | CA2078264A1 Substituted derivatives of piperizinylcamphorsulfonyl oxytocin antagonists |
03/17/1993 | CA2078263A1 Substituted alkyl derivatives of piperizinylcamphorsulfonyl oxytocin antagonists |
03/17/1993 | CA2078262A1 Hydantoin and succinimide-substituted derivatives of spiroindanylcamphorsulfonyl oxytocin antagonists |
03/17/1993 | CA2078025A1 Substituted amine derivatives of piperizinylcamphorsulfonyl oxytocin antagonists |
03/16/1993 | US5194670 Storage stability |
03/16/1993 | US5194654 Viricides for retroviral infections such as aids |
03/16/1993 | US5194645 Trans-pt (iv) compounds |
03/16/1993 | US5194644 Ethylene-substituted phenylalkylethylene-diamine-platinum (ii or iv) derivatives and phenylalkylethylenediamines |
03/16/1993 | US5194625 Process for production of alpha-keto acid/amino acid salt compounds |
03/16/1993 | US5194614 Antiischemic agents, analgesics, immunology, sedatives or hypoglycemic agents |
03/16/1993 | US5194611 Separation technique for a mixture of (6RS)-diastereoisomers of an ammonium salt of N5 -methyl-5,6,7,8-tetrahydrofolic acid into single (6R) and (6S)-diastereoisomers |
03/16/1993 | US5194605 Cyclic renin inhibitors containing 2-substituted (3S,4S)-4-amino-5-cyclohexyl-3-hydroxy pentanoic acid, 2-substituted (3S,4S)-5-cyclohexyl-3,4-di-hydroxy pentanoic acid or 2-substituted (4S,5S)-5-amino-6-cyclohexyl-4-hydroxyhexanoic acid or its analogs |
03/16/1993 | US5194604 Reacting a novel substrate with a beta lactam and a base |
03/16/1993 | US5194451 Administering a Higher Aliphatic Alcohol |
03/16/1993 | US5194449 Use of prostaglandin F3α as an ocular hypotensive agent |
03/16/1993 | US5194448 Use of nervonic acid and long chain fatty acids for the treatment of demyelinating disorders |
03/16/1993 | US5194446 Compounds having one or more aminosulfaonyloxy radicals useful as pharmaceuticals |
03/16/1993 | US5194440 Treatment for migraine; selective agonist |
03/16/1993 | US5194437 Substituted with oxygen containing heterocycle, central nervous system disorders, neuroendocrine disorders |
03/16/1993 | US5194434 Use of OB-101 to treat ocular inflammation |
03/16/1993 | US5194433 Improved effectiveness against resistant bacteria |
03/16/1993 | US5194432 Cephem compounds |
03/16/1993 | US5194431 24-cyclopropane vitamin D derivatives |
03/16/1993 | US5194430 Heterocyclic-nmda antagonists |
03/16/1993 | US5194429 Ocular hypotensive agents |
03/16/1993 | US5194428 Inhibition of influenza virus replication by oligonucleotide phosphorothioates |
03/16/1993 | US5194427 Antimycotic compositions of nikkomycin compounds and azole antimycotics |
03/16/1993 | US5194426 Method for nerve growth induction |
03/16/1993 | US5194378 Immunosuppressants |
03/16/1993 | US5194371 Production of pradimicin antibiotics |
03/16/1993 | US5194261 Diaper rash treatment |
03/16/1993 | US5194248 Compositions comprising vitamin D analog precursors and the use thereof |
03/16/1993 | US5194247 Synergistic skin depigmentation composition |
03/16/1993 | CA1314655C Hydroxylamine derivatives |
03/16/1993 | CA1314562C Antiarthritic beta-cyclo-alkyl-beta-oxopropionitriles |
03/16/1993 | CA1314553C Bicyclic compounds, processes for preparation thereof and pharmaceutical composition comprising the same |
03/16/1993 | CA1314551C Poly-4-aminopyrrole-2-carboxamido derivatives and their use as site specific alkylating agents |
03/16/1993 | CA1314547C L-glutamic acid derivatives |
03/16/1993 | CA1314545C Non-peptidic renin inhibitors |
03/16/1993 | CA1314544C 8-cyano-1-cyclopropyl-1,4-dihydro-4-oxo-3-quinoline- carboxylic acids, processes for their preparation and antibacterial agents containing these compounds |
03/16/1993 | CA1314541C 17.beta.-n-monosubstituted carbamoyl -4-aza-5.- androst-1-en-3-ones |
03/16/1993 | CA1314485C Pharmaceutical composition for piperidinoalkanol-decongestant combination |
03/16/1993 | CA1314484C Synergistic combination of azelastine and theophylline or azelastine and .beta.-mimetics |
03/16/1993 | CA1314483C Stabilization of 13,14-dihydro-15-ketoprostaglandins |
03/16/1993 | CA1314482C Intravaginal devices |
03/16/1993 | CA1314481C Liposomal preparation and antibiotic |
03/15/1993 | CA2078058A1 Imidazo-fused iso- and heterocycles, process for their preparation, compositions containing them and their use |
03/15/1993 | CA2078057A1 Substituted aminopropanes, processes for their preparation, and their use |
03/14/1993 | WO1993006100A1 NEW β-CARBOLIN DERIVATIVES, THEIR PREPARATION AND THEIR USE IN DRUGS |
03/14/1993 | CA2096138A1 .beta.-carboline derivatives their production and use in pharmaceutical agents |
03/14/1993 | CA2077993A1 Oligosaccharide aromatic glycoside sulfate |
03/14/1993 | CA2077922A1 Substituted amide derivatives of piperizinylcamphorsulfonyl oxytocin antagonists |
03/14/1993 | CA2076257A1 4-¬4-¬4-(4-hydroxyphenyl)-1- piperazinyl|phenyl|-5-methyl-3h -1,2,4-triazol-3-one derivatives |
03/13/1993 | CA2078030A1 Unsaturated acyclic phosphonate derivatives of purine and pyrimidine |
03/13/1993 | CA2077948A1 Further novel 5-amino-4-hydroxyhexanoic acid derivatives as therapeutic agents |
03/12/1993 | WO1993004684A1 Novel 4-arylpiperazines and 4-arylpiperidines |
03/12/1993 | CA2095826A1 4-arylpiperazines and 4-arylpiperidines |
03/11/1993 | DE4129779A1 Neue tricyclische thiazol- und oxazol-derivate und diese enthaltende arzneimittel Thiazole and oxazole novel tricyclic derivatives and pharmaceutical compositions containing them |
03/11/1993 | DE4129428A1 Use of phosphoric acid derivs. - to treat psoriasis, Karposi's sarcoma, neuro-dermatitis, allergy, acne and eczema |
03/11/1993 | CA2077967A1 N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present |
03/11/1993 | CA2077836A1 Process for the preparation of a cephalosporin antibiotic |
03/11/1993 | CA2077213A1 Bicyclic carboxylic acid derivatives |
03/10/1993 | EP0531253A1 N-substituted aminomethanediphosphonic acids |
03/10/1993 | EP0531228A1 Thiourea derivatives, antimicrobial agent and antiulcer agent containing the same |
03/10/1993 | EP0531219A1 Use of histamine derivatives for the preparation of drugs, new histamine derivatives and drugs |
03/10/1993 | EP0531119A1 N,N',N'-trisubstituted -5-bis-aminomethylene-1,3-dioxane-4,6-dione inhibitors of acyl-CoA: cholesterol-acyl transferase |
03/10/1993 | EP0531105A1 Use of felbamate for the manufacture of a medicament for the treatment of neuropsychopharmacological disorders |
03/10/1993 | EP0531078A1 (R)-3-Methoxy-4- 1-methyl-5-(2-methyl-4,4,4-trifluorobutylcarbamoyl)indol-3-ylmethyl -N-(2-methylsulphonyl)benzamide in crystalline form |
03/10/1993 | EP0531031A1 Compositions for use in cancer therapy |
03/10/1993 | EP0531026A1 Hexahydrobenzo[f]quinolinones as 5-alpha-reductase inhibitors |
03/10/1993 | EP0531016A2 Polysulfate of beta-cyclodextrin derivative and process for preparing the same |
03/10/1993 | EP0531001A1 Cyclic alkylmethylsiloxanes for skin care |
03/10/1993 | EP0530980A1 Neristatin 1 and a composition comprising the compound for the treatment of lymphocytic leukemia |
03/10/1993 | EP0530907A1 Indoles as inhibitors of HIV reverse transcriptase |
03/10/1993 | EP0530901A1 13-beta-O-methoxymethyl-22,23-dihydro avermectin B1A/B1B aglycone |
03/10/1993 | EP0530888A1 Fluoromacrolides having immunosuppressive activity |
03/10/1993 | EP0530887A1 Organic nitrates, processes for their preparation and their use in the treatment of cardiovascular diseases |
03/10/1993 | EP0530862A2 Dermatological cosmetic composition containing polyvitamined mixtures |
03/10/1993 | EP0530861A2 Topical antimicrobial pharmaceutical compositions |
03/10/1993 | EP0530804A1 Kits and compositions for the treatment and repair of defects or lesions in cartilage or bone |
03/10/1993 | EP0530702A1 1,2-dihydro-2-oxopyridines as angiotensin II antagonists |
03/10/1993 | EP0530639A1 Quinolylmethoxy-phenylacetamides substituted by a heterocycle as lipoxygenase inhibitors |
03/10/1993 | EP0530614A1 Novel antisense oligonucleotider with continuous phosphoramidate internucleotide linkage |
03/10/1993 | EP0530505A2 Hydantoin derivatives |
03/10/1993 | EP0530446A2 Use of sulfur containing carboxylic acids for combatting pathophysiologic excitatory disorders and related diseases as well as allergic diseases and their preparation as medicament |
03/10/1993 | EP0530444A1 Aryl, amide, imide, and carbamate pyridine antagonists of platelet activating factor |
03/10/1993 | EP0530407A1 Substituted, nucleoside derivatives, methods for their preparation and pharmaceutical compositions containing them |
03/10/1993 | EP0530355A1 Novel fluorine-containing quinolones and process for their preparation |
03/10/1993 | EP0530353A1 New imidazopyridines as serotonergic 5-ht 3? antagonists |
03/10/1993 | EP0530320A1 Processes for recovering tocotrienols, tocopherols and tocotrienol-like compounds |